- Home
- MNDY vs CAI Comparison
MNDY vs CAI Comparison
Compare MNDY & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNDY
- CAI
- Stock Information
- Founded
- MNDY 2012
- CAI 2008
- Country
- MNDY Israel
- CAI United States
- Employees
- MNDY N/A
- CAI N/A
- Industry
- MNDY Computer Software: Prepackaged Software
- CAI Medical Specialities
- Sector
- MNDY Technology
- CAI Health Care
- Exchange
- MNDY Nasdaq
- CAI Nasdaq
- Market Cap
- MNDY 9.5B
- CAI 8.9B
- IPO Year
- MNDY 2021
- CAI 2025
- Fundamental
- Price
- MNDY $195.94
- CAI $29.43
- Analyst Decision
- MNDY Strong Buy
- CAI Strong Buy
- Analyst Count
- MNDY 21
- CAI 6
- Target Price
- MNDY $298.19
- CAI $35.50
- AVG Volume (30 Days)
- MNDY 1.0M
- CAI 625.5K
- Earning Date
- MNDY 11-10-2025
- CAI 11-05-2025
- Dividend Yield
- MNDY N/A
- CAI N/A
- EPS Growth
- MNDY N/A
- CAI N/A
- EPS
- MNDY 0.76
- CAI N/A
- Revenue
- MNDY $1,100,240,000.00
- CAI $533,847,000.00
- Revenue This Year
- MNDY $28.70
- CAI $64.66
- Revenue Next Year
- MNDY $22.30
- CAI $45.81
- P/E Ratio
- MNDY $262.97
- CAI N/A
- Revenue Growth
- MNDY 30.24
- CAI 106.53
- 52 Week Low
- MNDY $166.22
- CAI $25.40
- 52 Week High
- MNDY $342.64
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- MNDY 55.07
- CAI N/A
- Support Level
- MNDY $176.00
- CAI N/A
- Resistance Level
- MNDY $202.31
- CAI N/A
- Average True Range (ATR)
- MNDY 6.53
- CAI 0.00
- MACD
- MNDY 2.25
- CAI 0.00
- Stochastic Oscillator
- MNDY 85.52
- CAI 0.00
About MNDY monday.com Ltd.
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.